This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 29/6/877    most recent ATVBAHA.109.184663v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by McGrath, K.C.Y. Articles by Heather, A.K. PubMed PubMed Citation Articles by McGrath, K.C.Y. Articles by Heather, A.K. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Compound via MeSH Substance via MeSH Related Collections Pathophysiology Gene expression Gene regulation Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:877.)
© 2009 American Heart Association, Inc.

Cell Biology/Signaling

Role of 3β-Hydroxysteroid-24 Reductase in Mediating Antiinflammatory Effects of High-Density Lipoproteins in Endothelial Cells

K.C.Y. McGrath; X.H. Li; R. Puranik; E.C. Liong; J.T.M. Tan; V.M. Dy; B.A. DiBartolo; P.J. Barter; K.A. Rye; A.K. Heather

From the Heart Research Institute (K.C.Y.M., X.H.L., R.P., E.C.L., J.T.M.T., V.M.D., B.A.D., P.J.B., K.A.R., A.K.H.), Camperdown; the Discipline of Medicine (X.H.L., R.P., B.A.D., P.J.B., K.A.R., A.K.H.), University of Sydney; and the Department of Medicine (K.A.R.), University of Melbourne, VIC, Australia.

Correspondence to Dr Alison Heather, Heart Research Institute, 114 Pyrmont Bridge Road, Camperdown, NSW, 2050, Australia. E-mail heathera{at}hri.org.au

Objective— The purpose of this study was to investigate the ability of high-density lipoproteins (HDLs) to upregulate genes with the potential to protect against inflammation in endothelial cells.

Methods and Results— Human coronary artery endothelial cells (HCAECs) were exposed to reconstituted HDLs (rHDLs) for 16 hours before being activated with tumor necrosis factor- (TNF-) for 5 hours. rHDLs decreased vascular cell adhesion molecule-1 (VCAM-1) promoter activity by 75% (P<0.05), via the nuclear factor-kappa B (NF-B) binding site. rHDLs suppressed the canonical NF-B pathway and decreased many NF-B target genes. Suppression of NF-B and VCAM-1 expression by rHDLs or native HDLs was dependent on an increase in 3β-hydroxysteroid-24 reductase (DHCR24) levels (P<0.05). The effect of HDLs on DHCR24 is dependent on SR-BI but not ABCAI or ABCGI. Silencing DHCR24 expression increased NF-B (1.2-fold, P<0.05), VCAM-1 (30-fold, P<0.05), and NF-B p50 (4-fold, P<0.05) and p65 subunits (150-fold, P<0.05). TNF- activation of siDHCR24-treated cells increased expression of VCAM-1 (550-fold, P<0.001) and NF-B (9-fold, P<0.001) that could no longer be suppressed by rHDLs.

Conclusions— Results suggest that antiinflammatory effects of rHDLs are mediated partly through an upregulation of DHCR24. These findings raise the possibility of considering DHCR24 as a target for therapeutic modulation.

This study investigates the ability of high-density lipoproteins (HDLs) to upregulate genes with the potential to protect against inflammation in endothelial cells. The results suggest that the effects of rHDLs are mediated through an upregulation of 3β-hydroxysteroid-24 reductase (DHCR24) that functioned as a negative regulator of nuclear factor-kappa B.

Key Words: atherosclerosis • endothelial cell • inflammation • nuclear factor-kappa B • 3β-hydroxysteroid-24 reductase

This article has been cited by other articles:

				CardioPulse Articles Eur. Heart J., November 1, 2009; 30(21): 2539 - 2550. [Full Text] [PDF]